 | PRD_000346 | Name: | N-{(2R)-3-phenyl-2-[(L-prolyl-L-threonyl-L-alpha-glutamyl)amino]propyl}-L-phenylalanyl-N~5~-[amino(iminio)methyl]-
L-ornithyl-L-glutamic acid | Formula: | C43 H63 N10 O12 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000347 | Name: | 1-acetyl-L-prolyl-L-valyl-L-tyrosyl-3-methyl-L-valyl-N~1~-[(1R)-1-phosphonoethyl]-L-glutamamide | Formula: | C33 H52 N7 O11 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000348 | Name: | N~1~-{(1S,2S,4S)-1-(cyclohexylmethyl)-4-[(2,2-dimethylpropyl)carbamoyl]-2-hydroxy-5-methylhexyl}-N~2~-(quinolin-2-ylcar
bonyl)-L-aspartamide | Formula: | C34 H51 N5 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000350 | Name: | SUCCINYL-ALA-ALA-PRO-LYS | Formula: | C21 H36 N5 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000351 | Name: | SUCCINYL-ALA-ALA-PRO-ARG | Formula: | C21 H36 N7 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000352 | Name: | N-(3-carboxypropanoyl)-L-alanyl-L-alanyl-L-prolyl-6-ammonio-N-(4-nitrophenyl)-L-norleucinamide | Formula: | C27 H40 N7 O9 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000354 | Name: | SUCCINYL-GLN-VAL-VAL-ALA-ALA-P-NITROANILIDE | Formula: | C31 H46 N8 O11 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000355 | Name: | N~2~-{(2S)-2-[(N-acetyl-4-carbamimidoyl-L-phenylalanyl)amino]-2-cyclohexylacetyl}-N~6~,N~6~-dimethyl-L-lysyl-
L-leucyl-L-prolinamide | Formula: | C39 H63 N9 O6 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000356 | Name: | N-[(1S)-2-{[(2S,3R,4S)-1-cyclohexyl-3,4-dihydroxy-6-methylheptan-2-yl]amino}-1-(ethylsulfanyl)-2-oxoethyl]-Nalpha-(morp
holin-4-ylsulfonyl)-L-phenylalaninamide | Formula: | C31 H52 N4 O7 S2 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000358 | Name: | (1R)-1-benzyl-1-methyl-1-(2-{[4-(1-methylethyl)phenyl]amino}-2-oxoethyl)-2-{(2S)-4-methyl-2-[(trifluoroacetyl)amino]pentanoyl}diazanium | Formula: | C27 H36 F3 N4 O3 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000361 | Name: | N~2~-[(2R)-2-benzyl-3-(tert-butylsulfonyl)propanoyl]-N-{(1R)-1-(cyclohexylmethyl)-3,3-difluoro-2,2-dihydroxy-4-[(2-morpholin-4-ylethyl)amino]-4-oxobutyl}-3-(1H-imidazol-3-ium-4-yl)-L-alaninamide | Formula: | C36 H56 F2 N7 O8 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000362 | Name: | INHIBITOR VAL-SER-GLN-ASN-LEU-PSI(CH(OH)-CH2)-VAL-ILE-VAL (U-85548E) | Formula: | C40 H73 N9 O12 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000363 | Name: | Ace-LEALFQ-ethylpropionate | Formula: | C40 H63 N7 O11 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000365 | Name: | 6-ammonio-N-(trifluoroacetyl)-L-norleucyl-N-[4-(1-methylethyl)phenyl]-L-prolinamide | Formula: | C22 H32 F3 N4 O3 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000367 | Name: | 6-ammonio-N-(trifluoroacetyl)-L-norleucyl-N-[4-(1-methylethyl)phenyl]-L-phenylalaninamide | Formula: | C26 H34 F3 N4 O3 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000368 | Name: | 6-ammonio-N-(trifluoroacetyl)-L-norleucyl-N-[4-(1-methylethyl)phenyl]-L-leucinamide | Formula: | C23 H36 F3 N4 O3 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000369 | Name: | D-phenylalanyl-N-[(2S,3S)-6-{[amino(iminio)methyl]amino}-1-chloro-2-hydroxyhexan-3-yl]-L-phenylalaninamide | Formula: | C25 H36 Cl N6 O3 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000374 | Name: | 3-[(2S)-2-{[(4-methylphenyl)sulfonyl]amino}-3-oxo-3-piperidin-1-ylpropyl]benzenecarboximidamide | Formula: | C22 H28 N4 O3 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000376 | Name: | amino{[(4S)-4-({[5-(dimethylamino)naphthalen-1-yl]sulfonyl}amino)-5-(4-ethylpiperidin-1-yl)-5-oxopentyl]amino}methaniminium | Formula: | C25 H39 N6 O3 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000378 | Name: | N-(ethoxycarbonyl)-L-leucyl-N-[(1R,2S,3S)-1-(cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl]-L-leucinamide | Formula: | C29 H55 N3 O6 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000379 | Name: | N-acetylated chloromethylated fibrinopeptide A | Formula: | C47 H75 Cl N13 O15 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000380 | Name: | N-[(1R)-1-carboxy-3-phenylpropyl]-L-leucyl-L-tryptophan | Formula: | C27 H33 N3 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000381 | Name: | SUCCINYL-ALA-ALA-PRO-PHE-CHLOROMETHYLKETONE | Formula: | C25 H35 Cl N4 O7 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000382 | Name: | N-[(1R,2R,4R)-1-(cyclohexylmethyl)-2-hydroxy-6-methyl-4-{[(2R)-2-methylbutyl]carbamoyl}heptyl]-3-(1H-imidazol-3-ium-4-y
l)-N~2~-[3-naphthalen-1-yl-2-(naphthalen-1-ylmethyl)propanoyl]-L-alaninamide | Formula: | C51 H68 N5 O4 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000388 | Name: | N-(tert-butoxycarbonyl)-L-alanyl-N-{(1S)-5-ammonio-1-[hydroxy(3-hydroxypropoxy)boranyl]pentyl}-L-valinamide | Formula: | C21 H44 B N4 O7 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|